Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR448851 in Early Alzheimer's Disease
NCT07688213Phase 2Recruiting
- Sponsor
- Sanofi
- Start
- Jul 2026
- Primary completion
- Jul 2029
- Countries
- 6
01
Overview
A Phase 2 trial of SAR448851 in Alzheimer's disease (AD), sponsored by Sanofi. Started Jul 2026; status: recruiting.
02
Drugs
SAR448851
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07688213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07688213.